Business Description
Nordhealth AS
ISIN : NO0011002651
Share Class Description:
STU:6E5: Ordinary SharesTotal Employee Number:
366Compare
Compare
Traded in other countries / regions
NORDH.Norway6E5.Germany IPO Date
2021-06-07Description
Nordhealth AS is a cloud-based healthcare Software-as-a-Service business. Its flagship Practice Management Software (PMS), Provet for veterinary practices and Therapy Unified Platform for therapy practices, assist healthcare professionals to streamline operations and improve patient care. The majority of its revenue is generated through software subscriptions. The Group also offers additional services related to the implementation of the SaaS systems, including consultancy services, education, and data conversion. Its operating segments are: Veterinary, which generates the majority of revenue, Therapy, and Other. Geographically, Nordhealth derives maximum revenue from Norway, and the rest from Finland, the United Kingdom, Sweden, Denmark, the DACH region, and other countries.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.8 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 7.44 | |||||
Beneish M-Score | -3.29 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 23.5 | |||||
3-Year EBITDA Growth Rate | 41 | |||||
3-Year EPS without NRI Growth Rate | -0.7 | |||||
3-Year FCF Growth Rate | 27.3 | |||||
3-Year Book Growth Rate | -10.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | -46.33 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 80.43 | |||||
9-Day RSI | 63.57 | |||||
14-Day RSI | 56 | |||||
3-1 Month Momentum % | 7.77 | |||||
6-1 Month Momentum % | -21.83 | |||||
12-1 Month Momentum % | -26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.65 | |||||
Quick Ratio | 1.65 | |||||
Cash Ratio | 1.03 | |||||
Days Sales Outstanding | 40.52 | |||||
Days Payable | 36.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.6 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 79.97 | |||||
Operating Margin % | -28.31 | |||||
Net Margin % | -29.26 | |||||
EBITDA Margin % | -5.61 | |||||
FCF Margin % | -12.81 | |||||
OCF Margin % | -2.94 | |||||
ROE % | -23.29 | |||||
ROA % | -19.59 | |||||
ROIC % | -23.52 | |||||
3-Year ROIIC % | -2.78 | |||||
ROC (Joel Greenblatt) % | -5151.44 | |||||
ROCE % | -22.07 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 3.29 | |||||
PB Ratio | 3.03 | |||||
Price-to-Tangible-Book | 16.46 | |||||
EV-to-EBIT | -10.84 | |||||
EV-to-EBITDA | -53.76 | |||||
EV-to-Revenue | 3.02 | |||||
EV-to-FCF | -23.22 | |||||
Price-to-GF-Value | 0.64 | |||||
| Price-to-Net-Current-Asset-Value | 19.45 | |||||
Earnings Yield (Greenblatt) % | -9.23 | |||||
FCF Yield % | -3.95 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nordhealth AS Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 51.829 | ||
| EPS (TTM) (€) | -0.193 | ||
| Beta | 0.8086 | ||
| 3-Year Sharpe Ratio | 0.12 | ||
| 3-Year Sortino Ratio | 0.19 | ||
| Volatility % | 43.19 | ||
| 14-Day RSI | 56 | ||
| 14-Day ATR (€) | 0.131568 | ||
| 20-Day SMA (€) | 2.0305 | ||
| 12-1 Month Momentum % | -26 | ||
| 52-Week Range (€) | 1.81 - 3.14 | ||
| Shares Outstanding (Mil) | 78.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nordhealth AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nordhealth AS Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-10 | In 107 days | ||
| Third quarter earnings results for 2026 | 2026-11-10 | In 107 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-18 | In 23 days | ||
| Second quarter earnings results for 2026 | 2026-08-18 | In 23 days | ||
| General meeting for 2026 | 2026-05-26 10:00 | 2.58 (-2.27%) | ||
| First quarter earnings conference call for 2026 | 2026-05-12 11:00 | 2.10 (-3.67%) | ||
| First quarter earnings results for 2026 | 2026-05-12 07:30 | 2.10 (-3.67%) | ||
| Annual report for 2025 | 2026-04-10 | 2.24 (+2.75%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-03 13:00 | 2.56 (-0.78%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-03 07:30 | 2.56 (-0.78%) |
Show
Entries
Nordhealth AS Frequently Asked Questions
What is Nordhealth AS(STU:6E5)'s stock price today?
The current price of STU:6E5 is €2.14. The 52 week high of STU:6E5 is €3.14 and 52 week low is €1.81.
When is next earnings date of Nordhealth AS(STU:6E5)?
The next earnings date of Nordhealth AS(STU:6E5) is 2026-08-18.
Does Nordhealth AS(STU:6E5) pay dividends? If so, how much?
Nordhealth AS(STU:6E5) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Nordhealth AS
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers